| Name | Cvs Pharmacy # 04402 |
|---|---|
| Organization Name | Ohio Cvs Stores Llc |
| Location | 1400 East 9th Street, Cleveland, Ohio 44114 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (216) 621-0132 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Retina Implant AG, a leading developer of subretinal implants for the visually impaired, today announced the presentation of findings obtained during their first human clinical trial in the form of two oral presentations at The Eye and the Chip 2010 Annual Meeting in Detroit, Mich.
In a study appearing in the March 22 New England Journal of Medicine, scientists supported by the National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) have discovered a connection between a specific gene and the inflammatory skin condition vitiligo, as well as a possible host of autoimmune diseases.
AstraZeneca (NYSE: AZN) accepted the 2009 Secretary of Defense Employer Support Freedom Award on Thursday at a ceremony in Washington, D.C. This award is the highest recognition given by the U.S. government to employers for their outstanding support of employees who serve in the National Guard and Reserve.
With governmental authorities, academicians, healthcare providers and industry grappling with the level of salt in the diet in an effort to reduce its impact on high blood pressure, new data evaluating a potential genetic component to salt-sensitive hypertension will be presented at the American Society of Hypertension, Inc.'s 25th Annual Scientific Meeting and Exposition (ASH 2010).
In a Policy Forum published this week in PLoS Medicine, Simon Capewell and Hilary Graham review different population strategies for preventing cardiovascular disease and conclude that screening and treating high-risk individuals may be ineffective and widen social inequalities. The authors conclude "there is evidence that CVD prevention strategies for screening and treating high-risk individuals may represent a relatively ineffective approach that typically widens social inequalities.
› Verified 7 days ago
| NPI Number | 1467555284 |
| Organization Name | OHIO CVS STORES LLC |
| Doing Business As | CVS PHARMACY 04402 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1400 E 9th St, Cleveland, OH 44114 |
| Phone Number | 216-621-0132 |
News Archive
Retina Implant AG, a leading developer of subretinal implants for the visually impaired, today announced the presentation of findings obtained during their first human clinical trial in the form of two oral presentations at The Eye and the Chip 2010 Annual Meeting in Detroit, Mich.
In a study appearing in the March 22 New England Journal of Medicine, scientists supported by the National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) have discovered a connection between a specific gene and the inflammatory skin condition vitiligo, as well as a possible host of autoimmune diseases.
AstraZeneca (NYSE: AZN) accepted the 2009 Secretary of Defense Employer Support Freedom Award on Thursday at a ceremony in Washington, D.C. This award is the highest recognition given by the U.S. government to employers for their outstanding support of employees who serve in the National Guard and Reserve.
With governmental authorities, academicians, healthcare providers and industry grappling with the level of salt in the diet in an effort to reduce its impact on high blood pressure, new data evaluating a potential genetic component to salt-sensitive hypertension will be presented at the American Society of Hypertension, Inc.'s 25th Annual Scientific Meeting and Exposition (ASH 2010).
In a Policy Forum published this week in PLoS Medicine, Simon Capewell and Hilary Graham review different population strategies for preventing cardiovascular disease and conclude that screening and treating high-risk individuals may be ineffective and widen social inequalities. The authors conclude "there is evidence that CVD prevention strategies for screening and treating high-risk individuals may represent a relatively ineffective approach that typically widens social inequalities.
› Verified 7 days ago
News Archive
Retina Implant AG, a leading developer of subretinal implants for the visually impaired, today announced the presentation of findings obtained during their first human clinical trial in the form of two oral presentations at The Eye and the Chip 2010 Annual Meeting in Detroit, Mich.
In a study appearing in the March 22 New England Journal of Medicine, scientists supported by the National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) have discovered a connection between a specific gene and the inflammatory skin condition vitiligo, as well as a possible host of autoimmune diseases.
AstraZeneca (NYSE: AZN) accepted the 2009 Secretary of Defense Employer Support Freedom Award on Thursday at a ceremony in Washington, D.C. This award is the highest recognition given by the U.S. government to employers for their outstanding support of employees who serve in the National Guard and Reserve.
With governmental authorities, academicians, healthcare providers and industry grappling with the level of salt in the diet in an effort to reduce its impact on high blood pressure, new data evaluating a potential genetic component to salt-sensitive hypertension will be presented at the American Society of Hypertension, Inc.'s 25th Annual Scientific Meeting and Exposition (ASH 2010).
In a Policy Forum published this week in PLoS Medicine, Simon Capewell and Hilary Graham review different population strategies for preventing cardiovascular disease and conclude that screening and treating high-risk individuals may be ineffective and widen social inequalities. The authors conclude "there is evidence that CVD prevention strategies for screening and treating high-risk individuals may represent a relatively ineffective approach that typically widens social inequalities.
› Verified 7 days ago
Health Care Solutions Type: Durable Medical Equipment & Medical Supplies Supplier Location: 9885 Rockside Rd, Cleveland, Ohio 44125 Phone: (216) 901-9250 | |
Giant Eagle Pharmacy #1263 Type: Pharmacy Location: 15325 Edgecliff Ave, Cleveland, Ohio 44111 Phone: (216) 671-6550 | |
Giant Eagle Pharmacy #0230 Type: Community/Retail Pharmacy Location: 3050 W 117th St, Cleveland, Ohio 44111 Phone: (216) 941-5109 | |
Giant Eagle Pharmacy #5817 Type: Community/Retail Pharmacy Location: 7939 Day Dr, Cleveland, Ohio 44129 Phone: (440) 888-7392 | |
Lincare Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4650 W 160th St, Cleveland, Ohio 44135 Phone: (216) 265-3039 |